Lexaria Bioscience Corp. (LEXX)

0.696 +0.07 (+10.48%) USD  |  NASDAQ  |  Feb 25, 16:00
0.7067 +0.01 (+1.54%) Pre-Market: 08:54
More

Lexaria Bioscience Reconciled Depreciation (Quarterly)

Reconciled Depreciation (Quarterly) Chart

View Reconciled Depreciation (Quarterly) for LEXX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Reconciled Depreciation (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Reconciled Depreciation (Quarterly) Range, Past 5 Years

View Reconciled Depreciation (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Reconciled Depreciation (Quarterly) Benchmarks

View Reconciled Depreciation (Quarterly) Benchmarks
Start Trial
Oncolytics Biotech, Inc. Upgrade
Aurinia Pharmaceuticals, Inc. Upgrade
Edesa Biotech, Inc. Upgrade
Xenon Pharmaceuticals, Inc. Upgrade
ProMIS Neurosciences, Inc. --